Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BeOne Medicines
AddedFeb 15, 2024
UpdatedJul 6, 2026
BeOne Medicines

BeOne Medicines

Public

BeiGene, a global biopharmaceutical firm, specializes in developing targeted and immuno-oncology cancer treatments.

HQ
Cambridge, MA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

BeiGene is a global biopharmaceutical company focused on the discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for cancer treatment. With operations in Cambridge, Massachusetts, and Beijing, China, BeiGene aims to advance an innovative, high-value product portfolio to benefit patients worldwide.

BeiGene has made significant strides in the biopharmaceutical industry, presenting new data from its SEQUOIA study and continuously working to improve cancer treatment options. The company unites worldwide talent and resources to support patients and their families, reflecting its commitment to improving global health outcomes.

BeOne Medicines - Similar Companies

Seagen logo

Seagen

seagen.com

Clovis Oncology logo

Clovis Oncology

Blueprint Medicines logo

Blueprint Medicines

Kronos Bio logo

Kronos Bio

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

BostonGene logo

BostonGene

bostongene.com

MacroGenics logo

MacroGenics

macrogenics.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Athenex logo

Athenex

Accelerated Pharma logo

Accelerated Pharma

MorphoSys logo

MorphoSys

morphosys.com

Foundation Medicine logo

Foundation Medicine

NextCure logo

NextCure

nextcure.com

Revolution Medicines logo

Revolution Medicines

revmed.com

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

BeOne Medicines - Quick Facts

Who are BeOne Medicines' competitors?

Companies similar to BeOne Medicines include Seagen, Clovis Oncology, Blueprint Medicines and Kronos Bio.

When was BeOne Medicines founded?

BeOne Medicines was founded in 2010.

Where is BeOne Medicines' headquarters located?

BeOne Medicines' headquarters is located in Cambridge, MA, US.

When was BeOne Medicines' last funding round?

BeOne Medicines' most recent funding round was for $2.1B (USD) in July 2020.

How much has BeOne Medicines raised to-date?

As of Jul 12, 2020, BeOne Medicines has raised a total of $6.8B (USD).

How many employees does BeOne Medicines have?

BeOne Medicines has 10,000 employees as of Feb 6, 2024.

BeOne Medicines - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Treatments
Tags
  • SaaS
Unique IDs
  • secCik: 0001651308
  • ticker: BEIGF
  • ticker: ONC
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research